Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Endocrine-Related Cancer

• Publication date

  2013-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/ERC-12-0281PMID 23744764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of target gene expression by the vitamin D receptor - an update on mechanisms

  2012cited by this paper
• Cancer statistics, 2012

  2012influential reference
• Cellular and molecular effects of vitamin D on carcinogenesis.

  2012cited by this paper
• Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.

  2012cited by this paper
• Vitamin D and colon cancer.

  2012cited by this paper
• Nuclear vitamin D receptor: Natural ligands, molecular structure-function, and transcriptional control of vital genes

  2011cited by this paper
• Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.

  2011cited by this paper
• Vitamin D and colon cancer

  2011cited by this paper
• Development of subtype-selective oestrogen receptor-based therapeutics

  2011cited by this paper
• Inhibitory Effects of Calcitriol on the Growth of MCF-7 Breast Cancer Xenografts in Nude Mice: Selective Modulation of Aromatase Expression in vivo

  2011cited by this paper
• Vitamin D metabolism in mammary gland and breast cancer.

  2011cited by this paper
• Current role and safety profile of aromatase inhibitors in early breast cancer

  2011cited by this paper
• Genome-wide principles of gene regulation by the vitamin D receptor and its activating ligand.

  2011cited by this paper
• Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling.

  2010cited by this paper
• American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

  2010cited by this paper
• The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer.

  2010cited by this paper
• The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25-dihydroxyvitamin D(3).

  2010cited by this paper
• American society of clinical oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.

  2010cited by this paper
• Tissue-Selective Regulation of Aromatase Expression by Calcitriol: Implications for Breast Cancer Therapy.

  2009cited by this paper
• Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy.

  2009cited by this paper
• Vitamin D signalling pathways in cancer: potential for anticancer therapeutics

  2007cited by this paper
• [Vitamin D and breast cancer].

  2007cited by this paper
• RETRACTED: 1α,25(OH)2D3-induced DNA methylation suppresses the human CYP27B1 gene

  2007cited by this paper
• 1alpha,25(OH)2D3-induced DNA methylation suppresses the human CYP27B1 gene.

  2007cited by this paper
• NF-Y Is Essential for the Recruitment of RNA Polymerase II and Inducible Transcription of Several CCAAT Box-Containing Genes

  2005influential reference
• Negative regulation of human parathyroid hormone gene promoter by vitamin D3 through nuclear factor Y.

  2005cited by this paper
• Calcitriol in cancer treatment: from the lab to the clinic.

  2004cited by this paper
• Suppression of the Human Parathyroid Hormone Promoter by Vitamin D Involves Displacement of NF-Y Binding to the Vitamin D Response Element*

  2004influential reference
• Retracted: Transrepression by a liganded nuclear receptor via a bHLH activator through co‐regulator switching

  2004cited by this paper
• Vitamin D3 receptor/Sp1 complex is required for the induction of p27Kip1 expression by vitamin D3

  2004cited by this paper
• Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells

  2004cited by this paper
• Retraction: ‘Transrepression by a liganded nuclear receptor via a bHLH activator through co‐regulator switching’

  2004cited by this paper
• Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter.

  2004influential reference
• Molecular basis of the selective activity of vitamin D analogues

  2003influential reference
• 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter.

  2002cited by this paper
• Vitamin D: Biology, Actions, and Clinical Implications

  2001cited by this paper
• 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.

  2000influential reference
• 1α,25-Dihydroxyvitamin D3 Down-Regulates Estrogen Receptor Abundance and Suppresses Estrogen Actions in MCF-7 Human Breast Cancer Cells

  2000influential reference
• Regulation of estrogen receptor-alpha gene expression by 1, 25-dihydroxyvitamin D in MCF-7 cells.

  1999cited by this paper
• The molecular biology of the CCAAT-binding factor NF-Y.

  1999cited by this paper
• Regulation of estrogen receptor‐α gene expression by 1,25‐dihydroxyvitamin D in MCF‐7 cells

  1999influential reference
• Sp1 and NF-Y Synergistically Mediate the Effect of Vitamin D3 in the p27Kip1 Gene Promoter That Lacks Vitamin D Response Elements*

  1999cited by this paper
• Identification of a vitamin D3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene.

  1996cited by this paper
• Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor

  1995cited by this paper
• Transcriptional regulation of estrogen receptor in breast carcinomas

  1995influential reference
• Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms.

  1994cited by this paper
• Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells.

  1994cited by this paper

• Targeting ERβ1-Positive Triple-Negative Breast Cancer: Molecular Effects of Calcitriol and 17β-Estradiol

  2025cites this paper
• Increased Antiproliferative Activity of Antiestrogens and Neratinib Treatment by Calcitriol in HER2-Positive Breast Cancer Cells

  2025cites this paper
• Vitamin D regulation of gut microbiota-derived butyrate as a potential inhibitor of breast cancer proliferation.

  2025cites this paper
• EB1089 Increases the Antiproliferative Response of Lapatinib in Combination with Antiestrogens in HER2-Positive Breast Cancer Cells

  2024cites this paper
• Vitamin D3 and Molecular Pathway of Skin Aging

  2023cites this paper
• Vitamin D May Protect against Breast Cancer through the Regulation of Long Noncoding RNAs by VDR Signaling

  2022cites this paper
• The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies

  2022cites this paper
• Association of Vitamin D Receptor and Vitamin D-Binding Protein Polymorphisms with Familial Breast Cancer Prognosis in a Mono-Institutional Cohort

  2021cites this paper
• Calcitriol induces estrogen receptor α expression through direct transcriptional regulation and epigenetic modifications in estrogen receptor-negative breast cancer cells.

  2021cites this paper
• Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update

  2021cites this paper
• Association of vitamin D deficiency and inflammatory cytokines with the clinicopathological features of breast cancer in female Saudi patients

  2021cites this paper
• Effect of Vitamin D Supplementation on Risk of Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2021cites this paper
• Vitamin D in Triple-Negative and BRCA1-Deficient Breast Cancer—Implications for Pathogenesis and Therapy

  2020cites this paper
• Vitamin D receptor (VDR) and metabolizing enzymes CYP27B1 and CYP24A1 in breast cancer

  2020cites this paper
• Vitamin D and its analogs as anticancer and anti-inflammatory agents.

  2020cites this paper
• Vitamin D as a Potential Therapeutic Option in Cancer Treatment: Is There a Role for Chemoprevention?

  2020cites this paper
• Single Nucleotide Polymorphisms in 25-Hydroxyvitamin D3 1-Alpha-Hydroxylase (CYP27B1) Gene: The Risk of Malignant Tumors and Other Chronic Diseases

  2020cites this paper
• 24R,25-dihydroxyvitamin D3 modulates tumorigenicity in breast cancer in an estrogen receptor-dependent manner.

  2019cites this paper
• 24R,25-Dihydroxyvitamin D3 regulates breast cancer cells in vitro and in vivo.

  2019cites this paper
• ERalpha isoforms modulate the tumorigenicity of 24R,25(OH)2D3 in estrogen-responsive cancer

  2019cites this paper
• Low pretreatment serum concentration of vitamin D at breast cancer diagnosis in postmenopausal women

  2019cites this paper
• Disrupting the IL-36 and IL-23/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis.

  2019cites this paper
• Insight into the roles of vitamins C and D against cancer: Myth or truth?

  2018cites this paper
• Activation of pro-survival metabolic networks by 1,25(OH)2D3 does not hamper the sensitivity of breast cancer cells to chemotherapeutics

  2018cites this paper
• Overview of vitamin D actions in cancer

  2018cites this paper
• The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences.

  2017cites this paper
• Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies

  2017cites this paper
• The Physiological/Pathophysiological Significance of Vitamin D in Cancer, Cardiovascular Disorders and Beyond.

  2017cites this paper
• Case study with natural substances on the various options to identify and categorise endocrine disruptors

  2017cites this paper
• Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D3.

  2017cites this paper
• Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.

  2017cites this paper
• Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer

  2016influential citation
• Down-Regulation of Ca2+-Activated K+ Channel KCa1.1 in Human Breast Cancer MDA-MB-453 Cells Treated with Vitamin D Receptor Agonists

  2016influential citation
• Vitamin D mitigates the adverse effects of obesity on breast cancer in mice.

  2016cites this paper
• Vitamin D and Mammographic Findings

  2016cites this paper
• Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer’s disease

  2016influential citation
• Relationship of Structure and Function of DNA-Binding Domain in Vitamin D Receptor

  2015cites this paper
• Estrogenic endocrine disruptors: Molecular mechanisms of action.

  2015cites this paper
• 1α,25-dihydroxyvitamin D3 inhibits cell growth and NFκB signaling in tamoxifen-resistant breast cancer cells.

  2014cites this paper
• Vitamin D as a regulator of steroidogenic enzymes

  2014cites this paper
• Investigation of Interactions between DNA and Nuclear Receptors: A Review of the Most Used Methods

  2014cites this paper
• Off-Label Uses of Topical Vitamin D in Dermatology: A Systematic Review

  2014cites this paper
• The role of vitamin D in reducing cancer risk and progression

  2014cites this paper
• Interaction of vitamin D with membrane-based signaling pathways

  2014cites this paper
• Vitamin D and the epigenome

  2014cites this paper
• Combined Effects of N-3 Polyunsaturated Fatty Acids and 1alpha, 25-dihydroxyvitamin D on Breast Cancer Cell Growth

  2013cites this paper
• Cell Lines

  1992cites this paper